Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision label was updated from Revision: v3.6.5 to Revision: v3.6.6, signaling a new build of the page rather than a substantive content change.SummaryDifference0.0%

- Check24 days agoChange DetectedA new NIH grant/contract entry, '2017 ( U.S. NIH Grant/Contract )', was added to the study's identifiers. This reflects funding information associated with the trial.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a newer build of the ClinicalTrials.gov interface. This change is a metadata update rather than a change to the study details or visible content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a routine update that does not alter study details or results.SummaryDifference0.0%

- Check74 days agoChange DetectedFooter now displays Revision: v3.6.3, replacing the previous v3.6.2. This update appears to be a metadata change to the page rendering rather than a modification to study content.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page’s revision tag has been updated to v3.6.2, signaling a software revision, while the previous v3.6.0 tag was removed.SummaryDifference0.0%

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.